Modular Medical will hold a conference call to discuss the clearance of the MODD1 pump, as well as next steps and milestones. Details for the conference call will be announced when available.
Modular Medical shares rose after hours as the company received Food and Drug Administration clearance for its MODD1 insulin pump. The stock was up 27%, to $2.49, surpassing the prior 52-week high ...
SAN DIEGO, CA / ACCESSWIRE / September 4, 2024 / Modular Medical ... Food and Drug Administration ("FDA") clearance of its MODD1 pump, as well as next steps and milestones. Conference Call ...
(the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery system technology company preparing to launch a market expansion product with a more accessible, easier to prescribe, and easier ...
Modular Medical will hold a conference call to discuss the clearance of the MODD1 pump, as well as next steps and milestones. Details for the conference call will be announced when available.